Review Article
The Role of Mesenchymal Stem Cells and Exosomes in Tumor Development and Targeted Antitumor Therapies
Table 4
MSC as delivery of oncolytic virus.
| | Cancer types | MSC groups | In vivo/in vitro | Agents | Route of administration | Main results | Reference |
| | Pancreatic tumor | BM-MSCs | In vivo and in vitro | OADV | i.v. | Tumor growth inhibition by induction of apoptotic cell death and degradation of tumor extracellular matrix | [74] | | Hepatocellular carcinoma | BM-MSCs | In vivo and in vitro | OADV | i.v. | OADV-MSC resulted in markedly 8.1-fold antitumor activity than OADV alone at 35 days postimplantation | [75] | | Colorectal cancer | MB-MSCs | In vivo and in vitro | OADV(CRAd5/F11) | Coculture in vitro i.v. in vivo | Inhibit tumor growth | [76] | | Lung cancer | AT-MSCs | In vivo an in vivo | OADV(ICOVIR5) | i.t. | Inhibit the growth of tumors in vivo | [77] | | Pancreatic cancer | BM-MSCs | In vitro | OADV | | Improved tumor cell killing | [78] | | Hepatocellular carcinoma | UC-MSCs | In vivo and in vitro | OADV | i.v. | Tumor inhibition on both orthotopic and subcutaneous hepatic xenograft tumor model mice | [79] | | Lung adenocarcinoma | MB-MSCs | In vivo | OADV(ICOVIR15-cBiTE) | i.p. | ICOVIR15-cBITE-loaded MB-MSCs enhance antitumor efficacy | [80] | | Malignant glioblastoma | BM-MSCs | In vivo and in vitro | OHSV | Stereotactically implanted into the brains | Induce apoptosis-mediated killing and prolonged median survival | [81] | | Brain metastatic melanomas | MSC and mMSC | In vivo and in vitro | OHSV | Intracarotid | Track metastatic tumor deposits in the brain, suppress brain tumor growth and prolong survival in mouse models of melanoma brain metastasis | [82] | | Breast cancer metastases to the brain/ovarian cancer lung metastases | Fetal membrane-derived MSCs | In vivo | OHSV | i.v. | Tumor growth inhibition of lung and brain metastases | [83] | | Liver cancer | BM-MSCs | In vivo | OMV | i.v. | Inhibition of tumor growth in both measles antibody-naïve and passively-immunized SCID mice | [84] | | Acute lymphoblastic leukemia | BM-MSCs | In vivo | OMV | i.v. | Inhibition of cancer development in a murine model of disseminated ALL following MSC-mediated delivery of OMV | [85] |
|
|
MSC: mesenchymal stem cells; UC-MSC: umbilical cord MSC; AT-MSC: adipose tissue MSC; BM-MSC: bone marrow MSC; OV: oncolytic virus; OADV: oncolytic adenovirus; OHSV: oncolytic herpes simplex virus; OMV: oncolytic measles virus.
|